Treatment of Hereditary Hemochromatosis in Juvenile Haemochromatosis or Severe Haemochromatosis with Life-Threatening Cardiac Iron Overload
Clinical Scenario
This protocol addresses patients with hereditary hemochromatosis who present with juvenile haemochromatosis, or with severe haemochromatosis complicated by life-threatening cardiac iron overload — a particularly urgent subset requiring specific therapeutic consideration.
Specific Conditions
Juvenile haemochromatosis is characterised by early-onset and often rapid iron accumulation. When severe haemochromatosis is associated with life-threatening cardiac iron overload, the clinical situation demands prompt and targeted intervention. In such cases, including those where severe clinical manifestations are present, the treatment approach may involve a combined or alternative strategy during the unloading phase.
Treatment Approach (Summary)
Therapeutic phlebotomy is the treatment of choice when feasible, with recognised efficacy across both the induction and maintenance phases — however, when it cannot be applied, the approach differs.
Full protocol details, including the complete management algorithm for cases where phlebotomy is not possible, are available via the structured regimen below.
References
DOI: 10.1016/j.jhep.2022.03.033
In juvenile haemochromatosis, phlebotomy has often been used and represents an effective therapeutic tool and the treatment of choice when possible.
In juvenile haemochromatosis, where chelation is typically begun in life-threatening cardiac iron overload, combination chelation therapy with oral DFP and intravenous DFO has been described in several case reports.
In the presence of severe clinical manifestations, a combined or alternative chelating therapy is generally required in the unloading phase.
View source ↗